Download PDF
1
/
Pages
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
Management of liver and gastrointestinal toxicity induced by immune checkpoint inhibitors: Position statement of the AEEH¿AEG¿SEPD¿SEOM¿GETECCU
Mar Riveiro-Barciela; Sabela Carballal; Álvaro Díaz-González; Míriam Mañosa; Javier Gallego-Plazas; Joaquín Cubiella; Paula Jiménez-Fonseca; María Varela; Luis Menchén; Bruno Sangro; Ana Fernández-Montes; Francisco Mesonero; Miguel Ángel Rodríguez-Gandía; Fernando Rivera; María-Carlota Londoño;
Gastroenterol Hepatol. 2024;47:401-32
Fenofibrate normalizes alkaline phosphatase and improves long-term outcomes in patients with advanced primary biliary cholangitis refractory to ursodeoxycholic acid
Dawei Ding; Pengwei Ren; Guanya Guo; Yansheng Liu; Chunmei Yang; Linhua Zheng; Gui Jia; Juan Deng; Ruiqing Sun; Xiufang Wang; Xinmin Zhou; Yulong Shang; Ying Han;
Gastroenterol Hepatol. 2023;46:692-701
Spanish Society of Primary Care Physicians (SEMERGEN) and Spanish Working Group on Crohn¿s Disease and Ulcerative Colitis (GETECCU) survey on the management of patients with inflammatory bowel disease
Daniel Ginard; Mercedes Ricote; Pilar Nos; M. Elena Pejenaute; Miquel Sans; Noelia Fontanillas; Manuel Barreiro-de Acosta; José Polo Garcia;
Gastroenterol Hepatol. 2023;46:647-56